Source: São Paulo Medical Journal. Unidade: FMRP
Subjects: ANEMIA FALCIFORME, HEMOGLOBINAS, DOENÇAS TORÁCICAS, FARMACOLOGIA
ABNT
SILVA-PINTO, Ana Cristina et al. Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil. São Paulo Medical Journal, v. 131, n. 4, p. 238-243, 2013Tradução . . Disponível em: https://doi.org/10.1590/1516-3180.2013.1314467. Acesso em: 08 nov. 2024.APA
Silva-Pinto, A. C., Angulo, I. L., Brunetta, D. M., Neves, F. I. R., Bassi, S. C., De Santis, G. C., & Covas, D. T. (2013). Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil. São Paulo Medical Journal, 131( 4), 238-243. doi:10.1590/1516-3180.2013.1314467NLM
Silva-Pinto AC, Angulo IL, Brunetta DM, Neves FIR, Bassi SC, De Santis GC, Covas DT. Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil [Internet]. São Paulo Medical Journal. 2013 ; 131( 4): 238-243.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1590/1516-3180.2013.1314467Vancouver
Silva-Pinto AC, Angulo IL, Brunetta DM, Neves FIR, Bassi SC, De Santis GC, Covas DT. Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil [Internet]. São Paulo Medical Journal. 2013 ; 131( 4): 238-243.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1590/1516-3180.2013.1314467